Latest News
Press Releases
May 18, 2022
IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program
April 7, 2022IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies
February 2, 2022IAVI appoints three notable global health and business leaders to its board of directors
January 27, 2022IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology
January 18, 2022IAVI Welcomes Marion F. Gruber as Vice President, Public Health and Regulatory Science
Features
July 6, 2022
Meet the IAVI scientist applying new and emerging technologies to one of the toughest challenges facing HIV vaccine researchers today
May 17, 2022HVAD 2022: An HIV vaccine developed with the people it seeks to benefit most
May 11, 2022Meet the IAVI scientist who developed a new HIV test for resource-limited settings
May 6, 2022IAVI salutes the confirmation of John Nkengasong as head of PEPFAR
March 17, 2022HVTN 302 begins first dosing of mRNA HIV vaccine antigens
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
